Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID.
Caron B, Seksik P, Buisson A, Wils P, Savoye G, Stefanescu C, Laharie D, Guillo L, Abitbol V, Bonnet J, Altwegg R, Vuitton L, Moussata D, Bourreille A, Biron A, Gilletta C, Fumery M, Nahon S, Nancey S, Camara H, Peyrin-Biroulet L.
Caron B, et al. Among authors: camara h.
Therap Adv Gastroenterol. 2024 Aug 7;17:17562848241265776. doi: 10.1177/17562848241265776. eCollection 2024.
Therap Adv Gastroenterol. 2024.
PMID: 39119370
Free PMC article.